Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alnylam and Dicerna form RNAi Therapeutics collaboration on alpha-1 liver disease
Alnylam and Dicerna form RNAi Therapeutics collaboration on alpha-1 liver disease. (Credit: Pete Linforth from Pixabay)
Alnylam and Dicerna form RNAi Therapeutics collaboration on alpha-1 liver disease. (Credit: Pete Linforth from Pixabay)